China to Finalize Looser Controls on Human Genetic Material This Year

00:00

00:00/00:00

Listen to this article 1x

What’s new: China’s top health regulator plans this year to finish off revisions to guidelines on how human genetic material can be used in the country amid complaints that current restrictions are choking innovation.

In its legislative work plan for this year, the National Health Commission (NHC) included an amendment to the Detailed Rules for the Implementation of the Regulation on the Administration of Human Genetic Resources. The NHC released the work plan last week.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

DIGEST HUB

Digest Hub

Back

Explore the story in 30 seconds

China’s National Health Commission (NHC) aims to revise guidelines on human genetic material usage by the end of the year.
Supervision of human genetic resources shifted from the Ministry of Science and Technology to the NHC due to a 2023 government reorganization.
Changes include streamlining administrative procedures and possibly relaxing controls on the use of genetic resources to foster innovation.

AI generated, for reference only

What Happened When

March 2023：: A government reorganization plan was unveiled during the National People’s Congress.

Earlier this year (2024)：: The NHC took over supervision of human genetic resources from the Ministry of Science and Technology.

By 2024：: China’s top health regulator plans to finish off revisions to guidelines on how human genetic material can be used in the country.

Last week：: The NHC released the legislative work plan for 2024, which included an amendment to the Detailed Rules for the Implementation of the Regulation on the Administration of Human Genetic Resources.

AI generated, for reference only